search
Back to results

Comparison of ENGBD and PTGBD in Acute Suppurative Cholecystitis

Primary Purpose

Success Rate

Status
Completed
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
Endoscopic naso-gallbladder drainage
Percutaneous gallbladder drainage
Sponsored by
Hepatopancreatobiliary Surgery Institute of Gansu Province
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Success Rate focused on measuring ERCP, PTGBD, ENGBD, Gallbladder drainage, Cholecystitis

Eligibility Criteria

18 Years - 90 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Acute suppurative cholecystitis
  • Who can not tolerate or unsuitable for cholecystectomy

Exclusion Criteria:

  • Unwillingness or inability to consent for the study
  • Coagulation dysfunction (INR> 1.5) and low peripheral blood platelet count (<50×10^9 / L) or using anti-coagulation drugs
  • Bile duct stones
  • Prior surgery of Bismuth Ⅱ, Roux-en-Y and Cholangiojejunostomy
  • Preoperative coexistent diseases: acute pancreatitis, GI tract hemorrhage or perforation, severe liver disease(such as decompensated liver cirrhosis, liver failure and so on), septic shock
  • Any malignant
  • Pregnant women or breastfeeding

Sites / Locations

  • Hepatopancreatobiliary Surgery Institute of Gansu Province

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Endoscopic naso-gallbladder drainage

Percutaneous gallbladder drainage

Arm Description

After selective bile duct cannulation, a 0.025- or 0.035-inch guidewire is advanced into the cystic duct and subsequently into the gallbladder. A 5F naso- Pancreas catheter was inserted into the gallbladder for ENGBD.

Ultrasound guided,an 18-gauge needle is inserted into the gallbladder,0.035 inch guidewire is coiled into the gallbladder and 9Fr dilator expands the skin,then 8Fr-20cm catheter is placed.

Outcomes

Primary Outcome Measures

Pain remission(visual-analogue scale)
Pain assessment would be performed using the visual-analogue scale after procedures. Draw a 10 cm line on a piece of paper, mark one end of the line with the nubmer 0, indicating no pain; the other end with 10, indicating severe pain; the middle part indicates different degrees of pain. While assesing the pain scale, make sure the patient can not see the numbers on the paper, and let them mark the position according to their feelings about the pain. And the physician will have a score based on the mark.

Secondary Outcome Measures

Gallbladder drainage success rate
Bile juice outflow more than 50ml a day
Migration
Number of participants with tube dislocation from gallbladder
Hemorrhage
Number of participants with bleeding which was defined as hemoglobin deceased, or required transfusion or additional intervention
Perforation
Number of participants whose CT scan shows retroperitoneal or gallbladder space fluid or gas
Bile leak
Number of participants with bile juice leak into abdomen
Number of participants with Pancreatitis
Was defined as typical pain, Serum amylase at least three times than normal after EPCP
Cholecystectomy duration
Time of laparoscopic cholecystectomy
Hemorrhage during cholecystectomy
The amount of bleeding

Full Information

First Posted
October 5, 2018
Last Updated
July 12, 2020
Sponsor
Hepatopancreatobiliary Surgery Institute of Gansu Province
search

1. Study Identification

Unique Protocol Identification Number
NCT03701464
Brief Title
Comparison of ENGBD and PTGBD in Acute Suppurative Cholecystitis
Official Title
Comparison of Clinical Efficacy Between ENGBD and PTGBD in Acute Suppurative Cholecystitis: a Single-center, Prospective Randomized Trial
Study Type
Interventional

2. Study Status

Record Verification Date
July 2020
Overall Recruitment Status
Completed
Study Start Date
October 10, 2018 (Actual)
Primary Completion Date
July 1, 2020 (Actual)
Study Completion Date
July 1, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Hepatopancreatobiliary Surgery Institute of Gansu Province

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Comparison of ENGBD and PTGBD methods on clinical outcomes and the difficulty of cholecystectomy in later stage in patients with acute suppurative cholecystitis.
Detailed Description
Laparoscopic cholecystectomy was the standard surgical method for acute cholecystitis unless difficulty in resection due to acute inflammation, no improvement after supportive therapy, or early inability to tolerate cholecystectomy. In this setting, gallbladder drainage was needed. Percutaneous transhepatic gallbladder drainage (PTGBD)was used as a first-line mitigation method, whose restrictions are contraindications and strong pain caused by puncture. Endoscopic technique based on endoscopic retrograde cholangiopancreatography (ERCP) had been made another alternative management for drainage. Endoscopic drainage expanded the indications for drainage without reducing the technical success rate and clinical remission rate, especially less uncomfortable, which greatly improved the quality of life for patients. Unfortunately, because of the difficult procedures and long learning curve, endoscopic gallbladder drainage can only be performed in some large endoscopic centers. Despite a few prospective comparison of PTGBD and endoscopic ultrasound EUS drainage studies so far, there is no prospective study comparing endoscopic naso-gallbladder drainage (ENGBD) and PTGBD, especially in its impacts while cholecystectomy. This study aim to observe clinical effects of ENGBD and PTGBD during the all stage of peri-cholecystectomy.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Success Rate
Keywords
ERCP, PTGBD, ENGBD, Gallbladder drainage, Cholecystitis

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
22 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Endoscopic naso-gallbladder drainage
Arm Type
Experimental
Arm Description
After selective bile duct cannulation, a 0.025- or 0.035-inch guidewire is advanced into the cystic duct and subsequently into the gallbladder. A 5F naso- Pancreas catheter was inserted into the gallbladder for ENGBD.
Arm Title
Percutaneous gallbladder drainage
Arm Type
Active Comparator
Arm Description
Ultrasound guided,an 18-gauge needle is inserted into the gallbladder,0.035 inch guidewire is coiled into the gallbladder and 9Fr dilator expands the skin,then 8Fr-20cm catheter is placed.
Intervention Type
Procedure
Intervention Name(s)
Endoscopic naso-gallbladder drainage
Intervention Description
Using ERCP technique insert a naso-gallbladder drainage tube through common bile duct and cystic duct.
Intervention Type
Procedure
Intervention Name(s)
Percutaneous gallbladder drainage
Intervention Description
Percutaneous transhepatic technique insert drainage tube into gallbladder
Primary Outcome Measure Information:
Title
Pain remission(visual-analogue scale)
Description
Pain assessment would be performed using the visual-analogue scale after procedures. Draw a 10 cm line on a piece of paper, mark one end of the line with the nubmer 0, indicating no pain; the other end with 10, indicating severe pain; the middle part indicates different degrees of pain. While assesing the pain scale, make sure the patient can not see the numbers on the paper, and let them mark the position according to their feelings about the pain. And the physician will have a score based on the mark.
Time Frame
3 weeks
Secondary Outcome Measure Information:
Title
Gallbladder drainage success rate
Description
Bile juice outflow more than 50ml a day
Time Frame
3 months
Title
Migration
Description
Number of participants with tube dislocation from gallbladder
Time Frame
3 months
Title
Hemorrhage
Description
Number of participants with bleeding which was defined as hemoglobin deceased, or required transfusion or additional intervention
Time Frame
3 months
Title
Perforation
Description
Number of participants whose CT scan shows retroperitoneal or gallbladder space fluid or gas
Time Frame
3 months
Title
Bile leak
Description
Number of participants with bile juice leak into abdomen
Time Frame
3 months
Title
Number of participants with Pancreatitis
Description
Was defined as typical pain, Serum amylase at least three times than normal after EPCP
Time Frame
3 months
Title
Cholecystectomy duration
Description
Time of laparoscopic cholecystectomy
Time Frame
3 months
Title
Hemorrhage during cholecystectomy
Description
The amount of bleeding
Time Frame
3 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Acute suppurative cholecystitis Who can not tolerate or unsuitable for cholecystectomy Exclusion Criteria: Unwillingness or inability to consent for the study Coagulation dysfunction (INR> 1.5) and low peripheral blood platelet count (<50×10^9 / L) or using anti-coagulation drugs Bile duct stones Prior surgery of Bismuth Ⅱ, Roux-en-Y and Cholangiojejunostomy Preoperative coexistent diseases: acute pancreatitis, GI tract hemorrhage or perforation, severe liver disease(such as decompensated liver cirrhosis, liver failure and so on), septic shock Any malignant Pregnant women or breastfeeding
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Xun Li, MD,PhD
Organizational Affiliation
Hepatopancreatobiliary Surgery Institute of Gansu Province
Official's Role
Study Director
Facility Information:
Facility Name
Hepatopancreatobiliary Surgery Institute of Gansu Province
City
Lanzhou
State/Province
Gansu
ZIP/Postal Code
730000
Country
China

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
22245666
Citation
Jang JW, Lee SS, Song TJ, Hyun YS, Park DY, Seo DW, Lee SK, Kim MH, Yun SC. Endoscopic ultrasound-guided transmural and percutaneous transhepatic gallbladder drainage are comparable for acute cholecystitis. Gastroenterology. 2012 Apr;142(4):805-11. doi: 10.1053/j.gastro.2011.12.051. Epub 2012 Jan 11.
Results Reference
background
PubMed Identifier
25952093
Citation
Kedia P, Sharaiha RZ, Kumta NA, Widmer J, Jamal-Kabani A, Weaver K, Benvenuto A, Millman J, Barve R, Gaidhane M, Kahaleh M. Endoscopic gallbladder drainage compared with percutaneous drainage. Gastrointest Endosc. 2015 Dec;82(6):1031-6. doi: 10.1016/j.gie.2015.03.1912. Epub 2015 May 5.
Results Reference
background
PubMed Identifier
25527052
Citation
Itoi T, Kawakami H, Katanuma A, Irisawa A, Sofuni A, Itokawa F, Tsuchiya T, Tanaka R, Umeda J, Ryozawa S, Doi S, Sakamoto N, Yasuda I. Endoscopic nasogallbladder tube or stent placement in acute cholecystitis: a preliminary prospective randomized trial in Japan (with videos). Gastrointest Endosc. 2015 Jan;81(1):111-8. doi: 10.1016/j.gie.2014.09.046.
Results Reference
background
PubMed Identifier
27343412
Citation
Khan MA, Atiq O, Kubiliun N, Ali B, Kamal F, Nollan R, Ismail MK, Tombazzi C, Kahaleh M, Baron TH. Efficacy and safety of endoscopic gallbladder drainage in acute cholecystitis: Is it better than percutaneous gallbladder drainage? Gastrointest Endosc. 2017 Jan;85(1):76-87.e3. doi: 10.1016/j.gie.2016.06.032. Epub 2016 Jun 22.
Results Reference
background
PubMed Identifier
33385126
Citation
Mu P, Lin Y, Zhang X, Lu Y, Yang M, Da Z, Gao L, Mi N, Li T, Liu Y, Wang H, Wang F, Leung JW, Yue P, Meng W, Zhou W, Li X. The evaluation of ENGBD versus PTGBD in high-risk acute cholecystitis: A single-center prospective randomized controlled trial. EClinicalMedicine. 2020 Dec 23;31:100668. doi: 10.1016/j.eclinm.2020.100668. eCollection 2021 Jan.
Results Reference
derived
PubMed Identifier
32080085
Citation
Mu P, Yue P, Li T, Bai B, Lin Y, Zhang J, Wang H, Liu Y, Yao J, Meng W, Li X. Comparison of endoscopic naso-gallbladder drainage and percutaneous transhepatic gallbladder drainage in acute suppurative cholecystitis: Study Protocol Clinical Trial (SPIRIT Compliant). Medicine (Baltimore). 2020 Feb;99(8):e19116. doi: 10.1097/MD.0000000000019116.
Results Reference
derived

Learn more about this trial

Comparison of ENGBD and PTGBD in Acute Suppurative Cholecystitis

We'll reach out to this number within 24 hrs